[{"address1": "2000 Sierra Point Parkway", "address2": "Suite 400", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "415 798 8589", "website": "https://www.tempesttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its clinical-stage lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.", "fullTimeEmployees": 24, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stephen R. Brady J.D., LLM", "age": 54, "title": "CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 894300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nicholas  Maestas", "age": 44, "title": "CFO, Head of Corporate Strategy & Secretary", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 465615, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Samuel  Whiting M.D., Ph.D.", "age": 58, "title": "Executive VP, Chief Medical Officer and Head of R&D", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 671387, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Justin  Trojanowski CPA", "age": 36, "title": "Corporate Controller, Treasurer & Principal Accounting Officer", "yearBorn": 1988, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lindsay  Young", "title": "Head of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.435, "open": 6.5, "dayLow": 6.4663, "dayHigh": 7.76, "regularMarketPreviousClose": 6.435, "regularMarketOpen": 6.5, "regularMarketDayLow": 6.4663, "regularMarketDayHigh": 7.76, "payoutRatio": 0.0, "beta": -2.302, "forwardPE": -5.6231885, "volume": 322350, "regularMarketVolume": 322350, "averageVolume": 120466, "averageVolume10days": 94220, "averageDailyVolume10Day": 94220, "bid": 7.67, "ask": 7.81, "bidSize": 1, "askSize": 1, "marketCap": 28575658, "fiftyTwoWeekLow": 5.356, "fiftyTwoWeekHigh": 28.34, "fiftyDayAverage": 6.90652, "twoHundredDayAverage": 10.001745, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 20169642, "profitMargins": 0.0, "floatShares": 3433459, "sharesOutstanding": 3682430, "sharesShort": 186244, "sharesShortPriorMonth": 439554, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0506, "heldPercentInsiders": 0.00124, "heldPercentInstitutions": 0.116409995, "shortRatio": 2.25, "shortPercentOfFloat": 0.0506, "impliedSharesOutstanding": 3682430, "bookValue": 3.163, "priceToBook": 2.453367, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -44799000, "trailingEps": -18.04, "forwardEps": -1.38, "lastSplitFactor": "1:13", "lastSplitDate": 1744156800, "enterpriseToEbitda": -0.452, "52WeekChange": -0.67733884, "SandP52WeekChange": 0.16932249, "quoteType": "EQUITY", "currentPrice": 7.76, "targetHighPrice": 9.0, "targetLowPrice": 9.0, "targetMeanPrice": 9.0, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 21511000, "totalCashPerShare": 5.842, "ebitda": -44619000, "totalDebt": 13105000, "quickRatio": 1.632, "currentRatio": 1.702, "debtToEquity": 117.713, "returnOnAssets": -0.73469, "returnOnEquity": -2.82065, "freeCashflow": -18534624, "operatingCashflow": -33877000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TPST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "shortName": "Tempest Therapeutics, Inc.", "longName": "Tempest Therapeutics, Inc.", "averageDailyVolume3Month": 120466, "fiftyTwoWeekLowChange": 2.4040003, "fiftyTwoWeekLowChangePercent": 0.44884247, "fiftyTwoWeekRange": "5.356 - 28.34", "fiftyTwoWeekHighChange": -20.58, "fiftyTwoWeekHighChangePercent": -0.72618204, "fiftyTwoWeekChangePercent": -67.73389, "dividendDate": 1544400000, "earningsTimestamp": 1747168097, "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754596800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -18.04, "epsForward": -1.38, "epsCurrentYear": -10.31, "priceEpsCurrentYear": -0.7526673, "fiftyDayAverageChange": 0.85348034, "fiftyDayAverageChangePercent": 0.12357604, "twoHundredDayAverageChange": -2.241745, "twoHundredDayAverageChangePercent": -0.22413538, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Tempest Therapeutics Inc.", "nameChangeDate": "2025-07-25", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1352730600000, "postMarketChangePercent": 1.80154, "postMarketPrice": 7.8998, "postMarketChange": 0.1398, "regularMarketChange": 1.325, "regularMarketDayRange": "6.4663 - 7.76", "fullExchangeName": "NasdaqCM", "corporateActions": [], "postMarketTime": 1753487940, "regularMarketTime": 1753473601, "exchange": "NCM", "messageBoardId": "finmb_552715229", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 20.5905, "regularMarketPrice": 7.76, "displayName": "Tempest Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-07-26"}]